)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Eris Lifesciences partners with Natco Pharma to commercialise semaglutide in India in 2026, as rising demand and impending patent expiry fuel intense competition in metabolic and weight-loss therapies
India will launch a nationwide, free and voluntary HPV vaccination campaign for 14-year-old girls, using Gardasil under strict quality norms, as part of efforts to eliminate cervical cancer
Firms upbeat as Delhi-Meerut RRTS now fully operational
Gurugram has surpassed Mumbai in luxury housing sales for the first time in five years, driven by HNI demand, new micro-markets and major infrastructure upgrades, a new report shows
Morepen Labs has secured a ₹825 crore multi-year CDMO mandate from a global pharma major, with supplies set to begin in 4-5 months and execution running through Q1 FY27
Indian auto and medical device exporters adopt wait-and-watch approach as US tariff shifts and refund uncertainty cloud shipment decisions
The decision follows the company's settlement with IDBI Trusteeship Services; the NCLT order further records that all pending applications in the matter stand disposed of
Ind-Ra says Indian drugmakers will still see 10% revenue growth in FY27 driven by domestic demand and CDMO traction, despite weaker US sales after Revlimid expiry
Premiumisation of housing fuels demand for larger units, with NCR, Chennai and Bengaluru posting the sharpest gains in average apartment sizes over two years
Macron announced plans to triple the number of Indian students in France and launched an Indo-French AI health centre, as both nations deepen cooperation in AI, mobility and nuclear R&D
Central Park will invest ₹1,200 crore in its new ultra-luxury Belanova project in Gurugram, targeting sales of up to ₹3,000 crore with phased pricing and strong early demand
AIOCD has urged the Prime Minister to ban AI-generated prescriptions, alleging they are being misused by unregulated e-pharmacies to sell restricted medicines, posing a serious public health risk
India's five listed REITs distributed over Rs 2,450 crore to 380,000 unitholders in Q3 FY26, backed by strong leasing momentum, improving occupancies and regulatory moves expanding access to capital
The pharmaceuticals department has invited stakeholder comments on proposed changes to the list of 350-plus medical devices exempt from GTE rules, with submissions open until February
Homes priced above ₹3 crore saw a 58% rise in lead-to-buy conversion time in 2025 as buyers became more selective, even as overall housing conversion time fell 18% due to faster big-ticket purchases
The steady migration of affluent households from other parts of Delhi towards South Delhi, driven by its superior social infrastructure, iconic value and lifestyle offering, has boosted demand
Board gives in-principle nod to make Biocon Biologics a wholly owned subsidiary as Q3 net profit climbs to Rs 143.8 crore
Joint centre, initiated by Union Education Ministry, will build scalable, human-centric AI systems for manufacturing sectors including semiconductors and robotics
Education Minister Dharmendra Pradhan chairs AI roundtable with edtech founders ahead of launch of IIT Madras-anchored Bharat Bodhan AI Foundation
Health Ministry proposes removing provisional registration for ethics committees, shifting to single-stage approval to streamline clinical research and cut regulatory delays